JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roth, B. L.
Right arrow Articles by Costa, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roth, B. L.
Right arrow Articles by Costa, E.

5-Hydroxytryptamine2 receptors coupled to phospholipase C in rat aorta: modulation of phosphoinositide turnover by phorbol ester

BL Roth, T Nakaki, DM Chuang and E Costa

In rat aorta, 5-hydroxytryptamine (5-HT) stimulated phosphoinositide (PI) turnover and contraction (EC50 = 10 +/- 3 microM); these two responses were highly correlated (r = 0.95; P less than .01). We have characterized the inhibitory potency of a variety of 5-HT-antagonists against the stimulation of PI turnover elicited by 5-HT. Classic 5-HT2 antagonists mianserin, ketanserin, metergoline and pizotifen were found to inhibit this response in the low nanomolar range; amitryptiline and haloperidol were 10- to 20-fold less potent. The alpha-1 receptor antagonist, prazosin, was inactive in micromolar concentrations. The potency of the 5-HT2 antagonists was correlated with their ability to displace [3H] ketanserin binding from rat frontal cortex membranes (r = 0.90; P less than .05). The tumor promoter phorbol dibutyrate was found to inhibit 5-HT-stimulated PI turnover at low nanomolar concentrations whereas the biologically inactive substance 4-alpha-phorbol was ineffective. Pretreatment of rat aorta with phorbol dibutyrate at concentrations that inhibited 5-HT-induced PI turnover also attenuated the aortic contraction induced by 5-HT in the presence of a calcium channel blocker nitrendipine. Our results suggest that phorbol esters may desensitize 5-HT2-receptor-mediated PI turnover and contraction of rat aorta, possibly via an activation of protein kinase C.

Volume 238, Issue 2, pp. 480-485, 08/01/1986
Copyright © 1986 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
R. T. Strachan, D. J. Sheffler, B. Willard, M. Kinter, J. G. Kiselar, and B. L. Roth
Ribosomal S6 Kinase 2 Directly Phosphorylates the 5-Hydroxytryptamine 2A (5-HT2A) Serotonin Receptor, Thereby Modulating 5-HT2A Signaling
J. Biol. Chem., February 27, 2009; 284(9): 5557 - 5573.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. Yu, J. Becnel, M. Zerfaoui, R. Rohatgi, A. H. Boulares, and C. D. Nichols
Serotonin 5-Hydroxytryptamine2A Receptor Activation Suppresses Tumor Necrosis Factor-{alpha}-Induced Inflammation with Extraordinary Potency
J. Pharmacol. Exp. Ther., November 1, 2008; 327(2): 316 - 323.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Shi, K. J. Damjanoska, R. K. Singh, G. A. Carrasco, F. Garcia, A. J. Grippo, M. Landry, N. R. Sullivan, G. Battaglia, and N. A. Muma
Agonist Induced-Phosphorylation of G{alpha}11 Protein Reduces Coupling to 5-HT2A Receptors
J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 248 - 256.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. H. Turner and J. R. Raymond
Interaction of Calmodulin with the Serotonin 5-Hydroxytryptamine2A Receptor: A PUTATIVE REGULATOR OF G PROTEIN COUPLING AND RECEPTOR PHOSPHORYLATION BY PROTEIN KINASE C
J. Biol. Chem., September 2, 2005; 280(35): 30741 - 30750.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. Sugiuar, K. Bielefeldt, and G. F. Gebhart
TRPV1 Function in Mouse Colon Sensory Neurons Is Enhanced by Metabotropic 5-Hydroxytryptamine Receptor Activation
J. Neurosci., October 27, 2004; 24(43): 9521 - 9530.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. J. Damjanoska, L. D. Van de Kar, G. H. Kindel, Y. Zhang, D. N. D'Souza, F. Garcia, G. Battaglia, and N. A. Muma
Chronic Fluoxetine Differentially Affects 5-Hydroxytryptamine2A Receptor Signaling in Frontal Cortex, Oxytocin- and Corticotropin-Releasing Factor-Containing Neurons in Rat Paraventricular Nucleus
J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 563 - 571.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Xia, J. A. Gray, B. A. Compton-Toth, and B. L. Roth
A Direct Interaction of PSD-95 with 5-HT2A Serotonin Receptors Regulates Receptor Trafficking and Signal Transduction
J. Biol. Chem., June 6, 2003; 278(24): 21901 - 21908.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. C. Quinn, N. N. Johnson-Farley, J. Yoon, and D. S. Cowen
Activation of Extracellular-Regulated Kinase by 5-Hydroxytryptamine2A Receptors in PC12 Cells is Protein Kinase C-Independent and Requires Calmodulin and Tyrosine Kinases
J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 746 - 752.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. K. S. Shum, J. A. Melendez, and J. J. Jeffrey
Serotonin-induced MMP-13 Production Is Mediated via Phospholipase C, Protein Kinase C, and ERK1/2 in Rat Uterine Smooth Muscle Cells
J. Biol. Chem., November 1, 2002; 277(45): 42830 - 42840.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. Day, P. A. Olson, J. Platzer, J. Striessnig, and D. J. Surmeier
Stimulation of 5-HT2 Receptors in Prefrontal Pyramidal Neurons Inhibits Cav1.2 L-Type Ca2+ Currents Via a PLCbeta /IP3/Calcineurin Signaling Cascade
J Neurophysiol, May 1, 2002; 87(5): 2490 - 2504.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. W. Watts
Serotonin-Induced Contraction in Mesenteric Resistance Arteries: Signaling and Changes in Deoxycorticosterone Acetate-Salt Hypertension
Hypertension, March 1, 2002; 39(3): 825 - 829.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. A. Berg, B. D. Stout, S. Maayani, and W. P. Clarke
Differences in Rapid Desensitization of 5-Hydroxytryptamine2A and 5-Hydroxytryptamine2C Receptor-Mediated Phospholipase C Activation
J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 593 - 602.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. A. Gray, D. J. Sheffler, A. Bhatnagar, J. A. Woods, S. J. Hufeisen, J. L. Benovic, and B. L. Roth
Cell-Type Specific Effects of Endocytosis Inhibitors on 5-Hydroxytryptamine2A Receptor Desensitization and Resensitization Reveal an Arrestin-, GRK2-, and GRK5-Independent Mode of Regulation in Human Embryonic Kidney 293 Cells
Mol. Pharmacol., November 1, 2001; 60(5): 1020 - 1030.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Rauser, J. E. Savage, H. Y. Meltzer, and B. L. Roth
Inverse Agonist Actions of Typical and Atypical Antipsychotic Drugs at the Human 5-Hydroxytryptamine2C Receptor
J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 83 - 89.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. M. McKune and S. W. Watts
Characterization of the Serotonin Receptor Mediating Contraction in the Mouse Thoracic Aorta and Signal Pathway Coupling
J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 88 - 95.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. Q. Teng, J. Williams, L. Zhang, R. Purdy, and W. J. Pearce
Effects of maturation, artery size, and chronic hypoxia on 5-HT receptor type in ovine cranial arteries
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1998; 275(3): R742 - R753.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1986 by the American Society for Pharmacology and Experimental Therapeutics.